Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Pharmacolog: Clinique Saint-Pierre Ottignies in Belgium selects DrugLog™

Perpetua Medical

Pharmacolog France SARL has received an order for a DrugLog™ system for placement at Clinique Saint-Pierre Ottignies (CSPO) in Belgium. The system will be used for the final check of chemotherapy preparations at the hospital pharmacy.

CSPO offers a range of diversified care in medicine, surgery, emergency care, ICU and oncology specialized in hematology. DrugLog™ will be used for the final control of pharmaceuticals compounded in an isolator in the clean room at the hospital pharmacy. The deployment will take place in June after which CSPO can begin the quality control of both cytotoxic drugs and antibodies. The order is expected to have only a minor impact on the result.

Didier Dubois, Sales Manager, Pharmacolog France SARL comments: "I am pleased that Clinique Saint-Pierre Ottignies has decided to use DrugLog™ to control their chemotherapy preparations. In both Belgium and France, interest in Pharmacolog's products is increasing significantly among pharmacists who want to increase medication safety by supplementing quality assurance of the hospital pharmacy's processes with quality control of the final products."

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.